News
-
Israeli pharmaceutical company Kamada has initiated a US Phase 2 trial of its inhaled alpha-1 antitrypsin (AAT) for the treatment of AAT deficiency, also known as inherited emphysema. The company also announced a delay in… Read more . . .
-
Medical Developments UK (MDUK) has announced that it will donate 25p from the sale of each of its pMDI spacers in the UK to Asthma UK. MDUK is part of Medical Developments International, whose Space… Read more . . .
-
CDMO Formex, formerly PharmaForm, has hired Steve Massah as President and CEO. Massah joins Formex from Gilead, where he worked in Strategic Drug Product Manufacturing and Outsourcing. He has previously held management positions with Avanir,… Read more . . .
-
According to St. Renatus, Blue Ocean Holdings is investing an additional $5 million in the company. The funds will go toward completion of St. Renatus’s New Drug Application (NDA) for its nasal mist dental anesthesia… Read more . . .
-
GSK and Theravance have announced that results from three phase 3 studies comparing the Anoro Ellipta umeclidinium/vilanterol DPI to Advair and Seretide Diskus in COPD patients show greater improvement in lung function for patients treated… Read more . . .
-
Alexza Pharmaceuticals has announced that its European partner Ferrer has launched Adasuve loxapine inhalation powder for the treatment of agitation in schizophrenic or bipolar patients in Romania. Ferrer has a distribution agreement with Galenica for… Read more . . .
-
Vectura has announced that it will acquire Activaero for a total of €130 million ($181 million). The company cited both Activaero’s nebulizer technology and its pipeline of respiratory drugs as part of the rationale for… Read more . . .
-
The New York Times has reported that Hunein “John” Maassab, who developed the FluMist intranasal live attenuated influenza vaccine (LAIV), died on February 1, 2014 in North Carolina. Dr. Maassab received a doctorate in epidemiology… Read more . . .
-
According to Hi-Tech Pharmacal, sales of its fluticasone propionate nasal spray dropped from $23 million in the 3rd quarter of the 2013 fiscal year to only $10.9 million for the same period in 2014. The… Read more . . .
-
Abstracts should be submitted by August 29, 2014 through either: 1) Online submission (IDDA website is under construction and will be announced upon completion.) 2) Email submission to: iddchina@126.com Abstracts should be no more than… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
May 10-May 14: RDD 2026, Phoenix, AZ, USA
May 15-May 16: ATS Respiratory Innovation Summit 2026, Orlando, FL, USA
May 17-May 20: ATS International Conference 2026, Orlando, FL, USA
June 10: SMI.London 2026, London, UK
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan